Minor
ATD · Adjuvant T-DM1 · HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Regina Elena Cancer InstituteNot specified NCT06272799 Registry history of NCT06272799 on ClinicalTrials.gov (opens the registry)
Changed